INCREASED DESENSITIZATION OF DOPAMINE D2 RECEPTOR-MEDIATED RESPONSE IN THE VENTRAL TEGMENTAL AREA IN THE ABSENCE OF ADENOSINE A2A RECEPTORS

被引:4
|
作者
Al-Hasani, R. [1 ]
Foster, J. D. [1 ]
Metaxas, A. [1 ]
Ledent, C. [2 ]
Hourani, S. M. O. [1 ]
Kitchen, I. [1 ]
Chen, Y. [1 ]
机构
[1] Univ Surrey, Div Biochem Sci, Fac Hlth & Med Sci, Surrey GU2 7XH, England
[2] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
adenosine A(2A) receptor; dopamine D-2 receptor; dopamine neuron; D-2 receptor desensitization; A(2A) receptor knockout mice; ventral tegmental area; KAPPA-OPIOID RECEPTORS; MICE LACKING; SUBSTANTIA-NIGRA; QUANTITATIVE AUTORADIOGRAPHY; EXTRACELLULAR DOPAMINE; MESSENGER-RNA; FIRING RATE; NEURONS; D2; BRAIN;
D O I
10.1016/j.neuroscience.2011.05.068
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
G-protein coupled receptors interact to provide additional regulatory mechanisms for neurotransmitter signaling. Adenosine A(2A) receptors are expressed at a high density in striatal neurons, where they closely interact with dopamine D-2 receptors and modulate effects of dopamine and responses to psychostimulants. A(2A) receptors are expressed at much lower densities in other forebrain neurons but play a more prominent yet opposing role to striatal receptors in response to psychostimulants in mice. It is, therefore, possible that A(2A) receptors expressed at low levels elsewhere in the brain may also regulate neurotransmitter systems and modulate neuronal functions. Dopamine D-2 receptors play an important role in autoinhibition of neuronal firing in dopamine neurons of the ventral tegmental area (VIA) and dopamine release in other brain areas. Here, we examined the effect of A(2A) receptor deletion on D-2 receptor-mediated inhibition of neuronal firing in dopamine neurons in the VTA. Spontaneous activity of dopamine neurons was recorded in midbrain slices, and concentration-dependent effects of the dopamine D-2 receptor agonist, quinpirole, was compared between wild-type and A(2A) knockout mice. The potency of quinpirole applied in single concentrations and the expression of D-2 receptors were not altered in the VTA of the knockout mice. However, quinpirole applied in stepwise escalating concentrations caused significantly reduced maximal inhibition in A(2A) knockout mice, indicating an enhanced agonist-induced desensitization of D-2 receptors in the absence of A(2A) receptors. The A(2A) receptor agonist, CGS21680, did not exert any effect on dopamine neuron firing or response to quinpirole, revealing a novel non-pharmacological interaction between adenosine A(2A) receptors and dopaminergic neurotransmission in midbrain dopamine neurons. Altered D-2 receptor desensitization may result in changes in dopamine neuron firing rate and pattern and dopamine release in other brain areas in response to persistent dopamine release and administration of psychostimulants. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 50 条
  • [1] DESENSITIZATION OF D2 DOPAMINE RECEPTORS IN THE VENTRAL TEGMENTAL AREA IS DISRUPTED BY ALCOHOL "DRINKING IN THE DARK"
    Brodie, M. S.
    You, C.
    Lasek, A. W.
    Chen, H.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 39 : 119A - 119A
  • [2] Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release
    Nimitvilai, Sudarat
    Herman, Melissa
    You, Chang
    Arora, Devinder S.
    McElvain, Maureen A.
    Roberto, Marisa
    Brodie, Mark S.
    NEUROPHARMACOLOGY, 2014, 82 : 28 - 40
  • [3] Adenosine A2A receptors modulate the dopamine D2 receptor-mediated inhibition of synaptic transmission in the mouse prefrontal cortex
    Real, Joana I.
    Simoes, Ana Patricia
    Cunha, Rodrigo A.
    Ferreira, Samira G.
    Rial, Daniel
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2018, 47 (09) : 1127 - 1134
  • [4] Effects of tetrahydroprotoberberines on dopamine D2 receptors in ventral tegmental area of rat
    王黎明
    张雪翔
    金国章
    Acta Pharmacologica Sinica, 1997, (02) : 48 - 51
  • [5] Trafficking of adenosine A2A and dopamine D2 receptors
    Torvinen, M
    Torri, C
    Tombesi, A
    Marcellino, D
    Watson, S
    Lluis, C
    Franco, R
    Fuxe, K
    Agnati, LF
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2005, 25 (02) : 191 - 200
  • [6] Trafficking of adenosine A2A and dopamine D2 receptors
    Maria Torvinen
    Carla Torri
    Andrea Tombesi
    Daniel Marcellino
    Stan Watson
    Carmen Lluis
    Rafael Franco
    Kjell Fuxe
    Luigi F. Agnati
    Journal of Molecular Neuroscience, 2005, 25 : 191 - 200
  • [7] Dopamine D2 and Adenosine A2A Receptors Regulate NMDA-Mediated Excitation in Accumbens Neurons Through A2A–D2 Receptor Heteromerization
    Karima Azdad
    David Gall
    Amina S Woods
    Catherine Ledent
    Sergi Ferré
    Serge N Schiffmann
    Neuropsychopharmacology, 2009, 34 : 972 - 986
  • [8] Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area
    Krabbe, Sabine
    Duda, Johanna
    Schiemann, Julia
    Poetschke, Christina
    Schneider, Gaby
    Kandel, Eric R.
    Liss, Birgit
    Roeper, Jochen
    Simpson, Eleanor H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (12) : E1498 - E1506
  • [9] Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats.: Interactions with adenosine A2A and dopamine D2 receptors
    Díaz-Cabiale, Z
    Vivó, M
    Del Arco, A
    O'Connor, WT
    Harte, MK
    Müller, CE
    Martínez, E
    Popoli, P
    Fuxe, K
    Ferré, S
    NEUROSCIENCE LETTERS, 2002, 324 (02) : 154 - 158
  • [10] Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680
    Schindler, CW
    Karcz-Kubicha, M
    Thorndike, EB
    Müller, CE
    Tella, SR
    Goldberg, SR
    Ferré, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 484 (2-3) : 269 - 275